nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—CYP3A7—Paclitaxel—ovarian cancer	0.101	0.137	CbGbCtD
Chlorphenamine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.101	0.137	CbGbCtD
Chlorphenamine—CYP3A5—Paclitaxel—ovarian cancer	0.0758	0.103	CbGbCtD
Chlorphenamine—CYP3A7—Docetaxel—ovarian cancer	0.0731	0.0989	CbGbCtD
Chlorphenamine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0731	0.0989	CbGbCtD
Chlorphenamine—CYP2D6—Vinorelbine—ovarian cancer	0.0662	0.0896	CbGbCtD
Chlorphenamine—CYP3A4—Topotecan—ovarian cancer	0.0597	0.0808	CbGbCtD
Chlorphenamine—CYP3A5—Docetaxel—ovarian cancer	0.0548	0.0742	CbGbCtD
Chlorphenamine—CYP3A4—Vinorelbine—ovarian cancer	0.0421	0.0569	CbGbCtD
Chlorphenamine—CYP3A4—Paclitaxel—ovarian cancer	0.0296	0.04	CbGbCtD
Chlorphenamine—CYP2D6—Doxorubicin—ovarian cancer	0.0251	0.0339	CbGbCtD
Chlorphenamine—CYP3A4—Docetaxel—ovarian cancer	0.0214	0.0289	CbGbCtD
Chlorphenamine—CYP3A4—Doxorubicin—ovarian cancer	0.0159	0.0216	CbGbCtD
Chlorphenamine—Hyporeflexia—Vinorelbine—ovarian cancer	0.00614	0.0262	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Altretamine—ovarian cancer	0.00565	0.0242	CcSEcCtD
Chlorphenamine—Neuritis—Chlorambucil—ovarian cancer	0.00491	0.021	CcSEcCtD
Chlorphenamine—Hyporeflexia—Paclitaxel—ovarian cancer	0.00413	0.0177	CcSEcCtD
Chlorphenamine—Vertigo—Altretamine—ovarian cancer	0.00405	0.0173	CcSEcCtD
Chlorphenamine—Convulsion—Altretamine—ovarian cancer	0.0039	0.0167	CcSEcCtD
Chlorphenamine—Dyskinesia—Chlorambucil—ovarian cancer	0.0039	0.0167	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Altretamine—ovarian cancer	0.0036	0.0154	CcSEcCtD
Chlorphenamine—Anorexia—Altretamine—ovarian cancer	0.00351	0.015	CcSEcCtD
Chlorphenamine—Chest tightness—Docetaxel—ovarian cancer	0.00339	0.0145	CcSEcCtD
Chlorphenamine—Decreased appetite—Altretamine—ovarian cancer	0.0032	0.0137	CcSEcCtD
Chlorphenamine—Fatigue—Altretamine—ovarian cancer	0.00317	0.0136	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.00295	0.0126	CcSEcCtD
Chlorphenamine—Asthenia—Altretamine—ovarian cancer	0.00264	0.0113	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Melphalan—ovarian cancer	0.00257	0.011	CcSEcCtD
Chlorphenamine—Neuritis—Paclitaxel—ovarian cancer	0.00251	0.0107	CcSEcCtD
Chlorphenamine—Dizziness—Altretamine—ovarian cancer	0.00243	0.0104	CcSEcCtD
Chlorphenamine—Hyporeflexia—Epirubicin—ovarian cancer	0.00236	0.0101	CcSEcCtD
Chlorphenamine—Vomiting—Altretamine—ovarian cancer	0.00234	0.01	CcSEcCtD
Chlorphenamine—Extrasystoles—Paclitaxel—ovarian cancer	0.00223	0.00953	CcSEcCtD
Chlorphenamine—Nausea—Altretamine—ovarian cancer	0.00218	0.00934	CcSEcCtD
Chlorphenamine—Hyporeflexia—Doxorubicin—ovarian cancer	0.00218	0.00934	CcSEcCtD
Chlorphenamine—Neuritis—Docetaxel—ovarian cancer	0.00213	0.00911	CcSEcCtD
Chlorphenamine—Chest discomfort—Paclitaxel—ovarian cancer	0.00212	0.00907	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00201	0.00859	CcSEcCtD
Chlorphenamine—Dyskinesia—Paclitaxel—ovarian cancer	0.002	0.00854	CcSEcCtD
Chlorphenamine—Hallucination—Chlorambucil—ovarian cancer	0.00183	0.00782	CcSEcCtD
Chlorphenamine—Wheezing—Paclitaxel—ovarian cancer	0.00182	0.00779	CcSEcCtD
Chlorphenamine—Chest discomfort—Docetaxel—ovarian cancer	0.0018	0.00768	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Topotecan—ovarian cancer	0.00179	0.00764	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Melphalan—ovarian cancer	0.00175	0.00749	CcSEcCtD
Chlorphenamine—Mental disability—Paclitaxel—ovarian cancer	0.00163	0.00696	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00153	0.00654	CcSEcCtD
Chlorphenamine—Tremor—Chlorambucil—ovarian cancer	0.0015	0.00641	CcSEcCtD
Chlorphenamine—Nasal congestion—Paclitaxel—ovarian cancer	0.0015	0.00639	CcSEcCtD
Chlorphenamine—Agitation—Chlorambucil—ovarian cancer	0.00147	0.00629	CcSEcCtD
Chlorphenamine—Chills—Topotecan—ovarian cancer	0.00147	0.00628	CcSEcCtD
Chlorphenamine—Agranulocytosis—Vinorelbine—ovarian cancer	0.00146	0.00623	CcSEcCtD
Chlorphenamine—Neuritis—Epirubicin—ovarian cancer	0.00144	0.00614	CcSEcCtD
Chlorphenamine—Convulsion—Chlorambucil—ovarian cancer	0.00139	0.00593	CcSEcCtD
Chlorphenamine—Neuritis—Doxorubicin—ovarian cancer	0.00133	0.00568	CcSEcCtD
Chlorphenamine—Confusional state—Chlorambucil—ovarian cancer	0.00132	0.00563	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00128	0.00547	CcSEcCtD
Chlorphenamine—Anorexia—Chlorambucil—ovarian cancer	0.00125	0.00533	CcSEcCtD
Chlorphenamine—Convulsion—Melphalan—ovarian cancer	0.00121	0.00517	CcSEcCtD
Chlorphenamine—Dyspepsia—Chlorambucil—ovarian cancer	0.00115	0.00492	CcSEcCtD
Chlorphenamine—Sweating increased—Paclitaxel—ovarian cancer	0.00115	0.0049	CcSEcCtD
Chlorphenamine—Dyskinesia—Epirubicin—ovarian cancer	0.00114	0.00488	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Topotecan—ovarian cancer	0.00114	0.00487	CcSEcCtD
Chlorphenamine—Decreased appetite—Chlorambucil—ovarian cancer	0.00114	0.00486	CcSEcCtD
Chlorphenamine—Fatigue—Chlorambucil—ovarian cancer	0.00113	0.00482	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Topotecan—ovarian cancer	0.00112	0.00481	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Melphalan—ovarian cancer	0.00112	0.00477	CcSEcCtD
Chlorphenamine—Tachycardia—Melphalan—ovarian cancer	0.00111	0.00475	CcSEcCtD
Chlorphenamine—Anorexia—Topotecan—ovarian cancer	0.00111	0.00474	CcSEcCtD
Chlorphenamine—Vertigo—Vinorelbine—ovarian cancer	0.0011	0.00468	CcSEcCtD
Chlorphenamine—Pollakiuria—Paclitaxel—ovarian cancer	0.00109	0.00465	CcSEcCtD
Chlorphenamine—Anorexia—Melphalan—ovarian cancer	0.00109	0.00464	CcSEcCtD
Chlorphenamine—Palpitations—Vinorelbine—ovarian cancer	0.00108	0.00461	CcSEcCtD
Chlorphenamine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00108	0.0046	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00107	0.00459	CcSEcCtD
Chlorphenamine—Hypotension—Melphalan—ovarian cancer	0.00106	0.00455	CcSEcCtD
Chlorphenamine—Dyskinesia—Doxorubicin—ovarian cancer	0.00106	0.00452	CcSEcCtD
Chlorphenamine—Hypertension—Vinorelbine—ovarian cancer	0.00105	0.0045	CcSEcCtD
Chlorphenamine—Paraesthesia—Topotecan—ovarian cancer	0.00104	0.00447	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00103	0.0044	CcSEcCtD
Chlorphenamine—Dyspepsia—Topotecan—ovarian cancer	0.00102	0.00438	CcSEcCtD
Chlorphenamine—Paraesthesia—Melphalan—ovarian cancer	0.00102	0.00437	CcSEcCtD
Chlorphenamine—Decreased appetite—Topotecan—ovarian cancer	0.00101	0.00432	CcSEcCtD
Chlorphenamine—Fatigue—Topotecan—ovarian cancer	0.001	0.00429	CcSEcCtD
Chlorphenamine—Dyspepsia—Melphalan—ovarian cancer	0.001	0.00429	CcSEcCtD
Chlorphenamine—Constipation—Topotecan—ovarian cancer	0.000995	0.00425	CcSEcCtD
Chlorphenamine—Decreased appetite—Melphalan—ovarian cancer	0.00099	0.00423	CcSEcCtD
Chlorphenamine—Fatigue—Melphalan—ovarian cancer	0.000982	0.0042	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000975	0.00417	CcSEcCtD
Chlorphenamine—Tachycardia—Vinorelbine—ovarian cancer	0.000971	0.00415	CcSEcCtD
Chlorphenamine—Feeling abnormal—Topotecan—ovarian cancer	0.000959	0.0041	CcSEcCtD
Chlorphenamine—Anorexia—Vinorelbine—ovarian cancer	0.000949	0.00406	CcSEcCtD
Chlorphenamine—Asthenia—Chlorambucil—ovarian cancer	0.000938	0.00401	CcSEcCtD
Chlorphenamine—Mental disability—Epirubicin—ovarian cancer	0.000931	0.00398	CcSEcCtD
Chlorphenamine—Hypotension—Vinorelbine—ovarian cancer	0.00093	0.00398	CcSEcCtD
Chlorphenamine—Diarrhoea—Chlorambucil—ovarian cancer	0.000894	0.00382	CcSEcCtD
Chlorphenamine—Paraesthesia—Vinorelbine—ovarian cancer	0.000894	0.00382	CcSEcCtD
Chlorphenamine—Photosensitivity—Epirubicin—ovarian cancer	0.000887	0.00379	CcSEcCtD
Chlorphenamine—Tinnitus—Paclitaxel—ovarian cancer	0.000879	0.00376	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000872	0.00373	CcSEcCtD
Chlorphenamine—Decreased appetite—Vinorelbine—ovarian cancer	0.000865	0.0037	CcSEcCtD
Chlorphenamine—Mental disability—Doxorubicin—ovarian cancer	0.000861	0.00368	CcSEcCtD
Chlorphenamine—Fatigue—Vinorelbine—ovarian cancer	0.000858	0.00367	CcSEcCtD
Chlorphenamine—Constipation—Vinorelbine—ovarian cancer	0.000851	0.00364	CcSEcCtD
Chlorphenamine—Chills—Paclitaxel—ovarian cancer	0.000845	0.00361	CcSEcCtD
Chlorphenamine—Asthenia—Topotecan—ovarian cancer	0.000835	0.00357	CcSEcCtD
Chlorphenamine—Vomiting—Chlorambucil—ovarian cancer	0.000831	0.00355	CcSEcCtD
Chlorphenamine—Agranulocytosis—Docetaxel—ovarian cancer	0.00083	0.00355	CcSEcCtD
Chlorphenamine—Photosensitivity—Doxorubicin—ovarian cancer	0.000821	0.00351	CcSEcCtD
Chlorphenamine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00082	0.00351	CcSEcCtD
Chlorphenamine—Asthenia—Melphalan—ovarian cancer	0.000817	0.00349	CcSEcCtD
Chlorphenamine—Tension—Paclitaxel—ovarian cancer	0.000805	0.00344	CcSEcCtD
Chlorphenamine—Nervousness—Paclitaxel—ovarian cancer	0.000797	0.00341	CcSEcCtD
Chlorphenamine—Diarrhoea—Topotecan—ovarian cancer	0.000796	0.0034	CcSEcCtD
Chlorphenamine—Diarrhoea—Melphalan—ovarian cancer	0.000779	0.00333	CcSEcCtD
Chlorphenamine—Diplopia—Epirubicin—ovarian cancer	0.000779	0.00333	CcSEcCtD
Chlorphenamine—Nausea—Chlorambucil—ovarian cancer	0.000776	0.00332	CcSEcCtD
Chlorphenamine—Vision blurred—Paclitaxel—ovarian cancer	0.000773	0.0033	CcSEcCtD
Chlorphenamine—Dizziness—Topotecan—ovarian cancer	0.000769	0.00329	CcSEcCtD
Chlorphenamine—Tremor—Paclitaxel—ovarian cancer	0.000769	0.00329	CcSEcCtD
Chlorphenamine—Agitation—Paclitaxel—ovarian cancer	0.000754	0.00322	CcSEcCtD
Chlorphenamine—Vomiting—Topotecan—ovarian cancer	0.00074	0.00316	CcSEcCtD
Chlorphenamine—Vertigo—Paclitaxel—ovarian cancer	0.000737	0.00315	CcSEcCtD
Chlorphenamine—Headache—Topotecan—ovarian cancer	0.000729	0.00312	CcSEcCtD
Chlorphenamine—Palpitations—Paclitaxel—ovarian cancer	0.000725	0.0031	CcSEcCtD
Chlorphenamine—Vomiting—Melphalan—ovarian cancer	0.000724	0.0031	CcSEcCtD
Chlorphenamine—Diplopia—Doxorubicin—ovarian cancer	0.000721	0.00308	CcSEcCtD
Chlorphenamine—Chills—Docetaxel—ovarian cancer	0.000717	0.00306	CcSEcCtD
Chlorphenamine—Asthenia—Vinorelbine—ovarian cancer	0.000714	0.00305	CcSEcCtD
Chlorphenamine—Convulsion—Paclitaxel—ovarian cancer	0.000711	0.00304	CcSEcCtD
Chlorphenamine—Hypertension—Paclitaxel—ovarian cancer	0.000708	0.00303	CcSEcCtD
Chlorphenamine—Anxiety—Paclitaxel—ovarian cancer	0.000696	0.00298	CcSEcCtD
Chlorphenamine—Nausea—Topotecan—ovarian cancer	0.000691	0.00295	CcSEcCtD
Chlorphenamine—Dry mouth—Paclitaxel—ovarian cancer	0.000683	0.00292	CcSEcCtD
Chlorphenamine—Diarrhoea—Vinorelbine—ovarian cancer	0.000681	0.00291	CcSEcCtD
Chlorphenamine—Nausea—Melphalan—ovarian cancer	0.000677	0.00289	CcSEcCtD
Chlorphenamine—Confusional state—Paclitaxel—ovarian cancer	0.000675	0.00289	CcSEcCtD
Chlorphenamine—Dizziness—Vinorelbine—ovarian cancer	0.000658	0.00281	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000655	0.0028	CcSEcCtD
Chlorphenamine—Tachycardia—Paclitaxel—ovarian cancer	0.000653	0.00279	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000647	0.00277	CcSEcCtD
Chlorphenamine—Anorexia—Paclitaxel—ovarian cancer	0.000638	0.00273	CcSEcCtD
Chlorphenamine—Vomiting—Vinorelbine—ovarian cancer	0.000633	0.00271	CcSEcCtD
Chlorphenamine—Hypotension—Paclitaxel—ovarian cancer	0.000626	0.00267	CcSEcCtD
Chlorphenamine—Headache—Vinorelbine—ovarian cancer	0.000624	0.00267	CcSEcCtD
Chlorphenamine—Pollakiuria—Epirubicin—ovarian cancer	0.000622	0.00266	CcSEcCtD
Chlorphenamine—Palpitations—Docetaxel—ovarian cancer	0.000614	0.00263	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000614	0.00263	CcSEcCtD
Chlorphenamine—Insomnia—Paclitaxel—ovarian cancer	0.000606	0.00259	CcSEcCtD
Chlorphenamine—Convulsion—Docetaxel—ovarian cancer	0.000602	0.00258	CcSEcCtD
Chlorphenamine—Paraesthesia—Paclitaxel—ovarian cancer	0.000601	0.00257	CcSEcCtD
Chlorphenamine—Hypertension—Docetaxel—ovarian cancer	0.0006	0.00257	CcSEcCtD
Chlorphenamine—Drowsiness—Epirubicin—ovarian cancer	0.0006	0.00257	CcSEcCtD
Chlorphenamine—Somnolence—Paclitaxel—ovarian cancer	0.000595	0.00254	CcSEcCtD
Chlorphenamine—Nausea—Vinorelbine—ovarian cancer	0.000591	0.00253	CcSEcCtD
Chlorphenamine—Dyspepsia—Paclitaxel—ovarian cancer	0.000589	0.00252	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000588	0.00251	CcSEcCtD
Chlorphenamine—Decreased appetite—Paclitaxel—ovarian cancer	0.000582	0.00249	CcSEcCtD
Chlorphenamine—Dry mouth—Docetaxel—ovarian cancer	0.000579	0.00247	CcSEcCtD
Chlorphenamine—Fatigue—Paclitaxel—ovarian cancer	0.000577	0.00247	CcSEcCtD
Chlorphenamine—Pollakiuria—Doxorubicin—ovarian cancer	0.000575	0.00246	CcSEcCtD
Chlorphenamine—Constipation—Paclitaxel—ovarian cancer	0.000572	0.00245	CcSEcCtD
Chlorphenamine—Confusional state—Docetaxel—ovarian cancer	0.000572	0.00245	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000568	0.00243	CcSEcCtD
Chlorphenamine—Agranulocytosis—Epirubicin—ovarian cancer	0.00056	0.00239	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000556	0.00238	CcSEcCtD
Chlorphenamine—Drowsiness—Doxorubicin—ovarian cancer	0.000555	0.00237	CcSEcCtD
Chlorphenamine—Tachycardia—Docetaxel—ovarian cancer	0.000554	0.00237	CcSEcCtD
Chlorphenamine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000552	0.00236	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000544	0.00233	CcSEcCtD
Chlorphenamine—Anorexia—Docetaxel—ovarian cancer	0.000541	0.00231	CcSEcCtD
Chlorphenamine—Hypotension—Docetaxel—ovarian cancer	0.00053	0.00227	CcSEcCtD
Chlorphenamine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000518	0.00222	CcSEcCtD
Chlorphenamine—Insomnia—Docetaxel—ovarian cancer	0.000513	0.00219	CcSEcCtD
Chlorphenamine—Paraesthesia—Docetaxel—ovarian cancer	0.00051	0.00218	CcSEcCtD
Chlorphenamine—Somnolence—Docetaxel—ovarian cancer	0.000504	0.00216	CcSEcCtD
Chlorphenamine—Tinnitus—Epirubicin—ovarian cancer	0.000502	0.00215	CcSEcCtD
Chlorphenamine—Dyspepsia—Docetaxel—ovarian cancer	0.000499	0.00214	CcSEcCtD
Chlorphenamine—Decreased appetite—Docetaxel—ovarian cancer	0.000493	0.00211	CcSEcCtD
Chlorphenamine—Fatigue—Docetaxel—ovarian cancer	0.000489	0.00209	CcSEcCtD
Chlorphenamine—Constipation—Docetaxel—ovarian cancer	0.000485	0.00207	CcSEcCtD
Chlorphenamine—Chills—Epirubicin—ovarian cancer	0.000483	0.00207	CcSEcCtD
Chlorphenamine—Asthenia—Paclitaxel—ovarian cancer	0.00048	0.00205	CcSEcCtD
Chlorphenamine—Feeling abnormal—Docetaxel—ovarian cancer	0.000468	0.002	CcSEcCtD
Chlorphenamine—Tinnitus—Doxorubicin—ovarian cancer	0.000465	0.00199	CcSEcCtD
Chlorphenamine—Tension—Epirubicin—ovarian cancer	0.00046	0.00197	CcSEcCtD
Chlorphenamine—Diarrhoea—Paclitaxel—ovarian cancer	0.000458	0.00196	CcSEcCtD
Chlorphenamine—Nervousness—Epirubicin—ovarian cancer	0.000455	0.00195	CcSEcCtD
Chlorphenamine—Chills—Doxorubicin—ovarian cancer	0.000447	0.00191	CcSEcCtD
Chlorphenamine—Dizziness—Paclitaxel—ovarian cancer	0.000443	0.00189	CcSEcCtD
Chlorphenamine—Vision blurred—Epirubicin—ovarian cancer	0.000442	0.00189	CcSEcCtD
Chlorphenamine—Agitation—Epirubicin—ovarian cancer	0.000431	0.00184	CcSEcCtD
Chlorphenamine—Tension—Doxorubicin—ovarian cancer	0.000426	0.00182	CcSEcCtD
Chlorphenamine—Vomiting—Paclitaxel—ovarian cancer	0.000426	0.00182	CcSEcCtD
Chlorphenamine—Nervousness—Doxorubicin—ovarian cancer	0.000421	0.0018	CcSEcCtD
Chlorphenamine—Vertigo—Epirubicin—ovarian cancer	0.000421	0.0018	CcSEcCtD
Chlorphenamine—Headache—Paclitaxel—ovarian cancer	0.000419	0.00179	CcSEcCtD
Chlorphenamine—Palpitations—Epirubicin—ovarian cancer	0.000414	0.00177	CcSEcCtD
Chlorphenamine—Vision blurred—Doxorubicin—ovarian cancer	0.000409	0.00175	CcSEcCtD
Chlorphenamine—Asthenia—Docetaxel—ovarian cancer	0.000407	0.00174	CcSEcCtD
Chlorphenamine—Convulsion—Epirubicin—ovarian cancer	0.000406	0.00174	CcSEcCtD
Chlorphenamine—Hypertension—Epirubicin—ovarian cancer	0.000405	0.00173	CcSEcCtD
Chlorphenamine—Agitation—Doxorubicin—ovarian cancer	0.000399	0.0017	CcSEcCtD
Chlorphenamine—Anxiety—Epirubicin—ovarian cancer	0.000398	0.0017	CcSEcCtD
Chlorphenamine—Nausea—Paclitaxel—ovarian cancer	0.000398	0.0017	CcSEcCtD
Chlorphenamine—Dry mouth—Epirubicin—ovarian cancer	0.00039	0.00167	CcSEcCtD
Chlorphenamine—Vertigo—Doxorubicin—ovarian cancer	0.00039	0.00167	CcSEcCtD
Chlorphenamine—Diarrhoea—Docetaxel—ovarian cancer	0.000388	0.00166	CcSEcCtD
Chlorphenamine—Confusional state—Epirubicin—ovarian cancer	0.000386	0.00165	CcSEcCtD
Chlorphenamine—Palpitations—Doxorubicin—ovarian cancer	0.000383	0.00164	CcSEcCtD
Chlorphenamine—Convulsion—Doxorubicin—ovarian cancer	0.000376	0.00161	CcSEcCtD
Chlorphenamine—Dizziness—Docetaxel—ovarian cancer	0.000375	0.0016	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000375	0.0016	CcSEcCtD
Chlorphenamine—Hypertension—Doxorubicin—ovarian cancer	0.000375	0.0016	CcSEcCtD
Chlorphenamine—Tachycardia—Epirubicin—ovarian cancer	0.000374	0.0016	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00037	0.00158	CcSEcCtD
Chlorphenamine—Anxiety—Doxorubicin—ovarian cancer	0.000368	0.00157	CcSEcCtD
Chlorphenamine—Anorexia—Epirubicin—ovarian cancer	0.000365	0.00156	CcSEcCtD
Chlorphenamine—Dry mouth—Doxorubicin—ovarian cancer	0.000361	0.00154	CcSEcCtD
Chlorphenamine—Vomiting—Docetaxel—ovarian cancer	0.000361	0.00154	CcSEcCtD
Chlorphenamine—Hypotension—Epirubicin—ovarian cancer	0.000358	0.00153	CcSEcCtD
Chlorphenamine—Confusional state—Doxorubicin—ovarian cancer	0.000357	0.00153	CcSEcCtD
Chlorphenamine—Headache—Docetaxel—ovarian cancer	0.000355	0.00152	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000347	0.00148	CcSEcCtD
Chlorphenamine—Insomnia—Epirubicin—ovarian cancer	0.000346	0.00148	CcSEcCtD
Chlorphenamine—Tachycardia—Doxorubicin—ovarian cancer	0.000346	0.00148	CcSEcCtD
Chlorphenamine—Paraesthesia—Epirubicin—ovarian cancer	0.000344	0.00147	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000342	0.00146	CcSEcCtD
Chlorphenamine—Somnolence—Epirubicin—ovarian cancer	0.00034	0.00145	CcSEcCtD
Chlorphenamine—Anorexia—Doxorubicin—ovarian cancer	0.000338	0.00144	CcSEcCtD
Chlorphenamine—Nausea—Docetaxel—ovarian cancer	0.000337	0.00144	CcSEcCtD
Chlorphenamine—Dyspepsia—Epirubicin—ovarian cancer	0.000337	0.00144	CcSEcCtD
Chlorphenamine—Decreased appetite—Epirubicin—ovarian cancer	0.000333	0.00142	CcSEcCtD
Chlorphenamine—Hypotension—Doxorubicin—ovarian cancer	0.000331	0.00141	CcSEcCtD
Chlorphenamine—Fatigue—Epirubicin—ovarian cancer	0.00033	0.00141	CcSEcCtD
Chlorphenamine—Constipation—Epirubicin—ovarian cancer	0.000327	0.0014	CcSEcCtD
Chlorphenamine—Insomnia—Doxorubicin—ovarian cancer	0.00032	0.00137	CcSEcCtD
Chlorphenamine—Paraesthesia—Doxorubicin—ovarian cancer	0.000318	0.00136	CcSEcCtD
Chlorphenamine—Feeling abnormal—Epirubicin—ovarian cancer	0.000315	0.00135	CcSEcCtD
Chlorphenamine—Somnolence—Doxorubicin—ovarian cancer	0.000315	0.00135	CcSEcCtD
Chlorphenamine—Dyspepsia—Doxorubicin—ovarian cancer	0.000312	0.00133	CcSEcCtD
Chlorphenamine—Decreased appetite—Doxorubicin—ovarian cancer	0.000308	0.00132	CcSEcCtD
Chlorphenamine—Fatigue—Doxorubicin—ovarian cancer	0.000305	0.00131	CcSEcCtD
Chlorphenamine—Constipation—Doxorubicin—ovarian cancer	0.000303	0.00129	CcSEcCtD
Chlorphenamine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000292	0.00125	CcSEcCtD
Chlorphenamine—Asthenia—Epirubicin—ovarian cancer	0.000275	0.00117	CcSEcCtD
Chlorphenamine—Diarrhoea—Epirubicin—ovarian cancer	0.000262	0.00112	CcSEcCtD
Chlorphenamine—Asthenia—Doxorubicin—ovarian cancer	0.000254	0.00109	CcSEcCtD
Chlorphenamine—Dizziness—Epirubicin—ovarian cancer	0.000253	0.00108	CcSEcCtD
Chlorphenamine—Vomiting—Epirubicin—ovarian cancer	0.000243	0.00104	CcSEcCtD
Chlorphenamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000242	0.00104	CcSEcCtD
Chlorphenamine—Headache—Epirubicin—ovarian cancer	0.00024	0.00103	CcSEcCtD
Chlorphenamine—Dizziness—Doxorubicin—ovarian cancer	0.000234	0.001	CcSEcCtD
Chlorphenamine—Nausea—Epirubicin—ovarian cancer	0.000227	0.000972	CcSEcCtD
Chlorphenamine—Vomiting—Doxorubicin—ovarian cancer	0.000225	0.000963	CcSEcCtD
Chlorphenamine—Headache—Doxorubicin—ovarian cancer	0.000222	0.000948	CcSEcCtD
Chlorphenamine—Nausea—Doxorubicin—ovarian cancer	0.00021	0.000899	CcSEcCtD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.78e-05	0.00248	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	6.75e-05	0.00247	CbGpPWpGaD
Chlorphenamine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	6.71e-05	0.00245	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—STAT3—ovarian cancer	6.69e-05	0.00244	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	6.52e-05	0.00238	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.5e-05	0.00238	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—MAPK3—ovarian cancer	6.4e-05	0.00234	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	6.38e-05	0.00233	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.32e-05	0.00231	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—CYP1B1—ovarian cancer	6.3e-05	0.0023	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	6.29e-05	0.0023	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—CYP1B1—ovarian cancer	6.21e-05	0.00227	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—MAPK1—ovarian cancer	6.09e-05	0.00222	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	6.08e-05	0.00222	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.06e-05	0.00221	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	5.93e-05	0.00217	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CASP3—ovarian cancer	5.68e-05	0.00207	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.65e-05	0.00206	CbGpPWpGaD
Chlorphenamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.51e-05	0.00201	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	5.47e-05	0.002	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—NME2—ovarian cancer	5.31e-05	0.00194	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—NME2—ovarian cancer	5.3e-05	0.00194	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—PIK3CA—ovarian cancer	5.28e-05	0.00193	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.14e-05	0.00188	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—NME2—ovarian cancer	4.94e-05	0.00181	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	4.82e-05	0.00176	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.79e-05	0.00175	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	4.48e-05	0.00164	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	4.42e-05	0.00161	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—PTEN—ovarian cancer	4.35e-05	0.00159	CbGpPWpGaD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—AKT1—ovarian cancer	4.31e-05	0.00158	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.26e-05	0.00155	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HSD17B6—ovarian cancer	4.2e-05	0.00153	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.11e-05	0.0015	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	3.9e-05	0.00142	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—NME2—ovarian cancer	3.84e-05	0.0014	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.77e-05	0.00138	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.64e-05	0.00133	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DLC1—ovarian cancer	3.57e-05	0.0013	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.43e-05	0.00125	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYTB—ovarian cancer	3.42e-05	0.00125	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYTB—ovarian cancer	3.42e-05	0.00125	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—IL6—ovarian cancer	3.33e-05	0.00122	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.31e-05	0.00121	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.25e-05	0.00119	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.2e-05	0.00117	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYTB—ovarian cancer	3.19e-05	0.00116	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.09e-05	0.00113	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—BRIP1—ovarian cancer	2.99e-05	0.00109	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PPP1CC—ovarian cancer	2.99e-05	0.00109	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—BRIP1—ovarian cancer	2.99e-05	0.00109	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PPP1CC—ovarian cancer	2.99e-05	0.00109	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—TP53—ovarian cancer	2.97e-05	0.00109	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.93e-05	0.00107	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—BCL9—ovarian cancer	2.91e-05	0.00106	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.89e-05	0.00105	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.87e-05	0.00105	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PPP1CC—ovarian cancer	2.78e-05	0.00102	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—BRIP1—ovarian cancer	2.78e-05	0.00102	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—NME2—ovarian cancer	2.73e-05	0.000997	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—IL6—ovarian cancer	2.72e-05	0.000994	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.71e-05	0.000989	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.62e-05	0.000955	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYTB—ovarian cancer	2.47e-05	0.000904	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.46e-05	0.0009	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.44e-05	0.00089	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—DOK1—ovarian cancer	2.3e-05	0.000841	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.3e-05	0.000839	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	2.21e-05	0.000808	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.17e-05	0.000794	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PPP1CC—ovarian cancer	2.16e-05	0.000791	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—BRIP1—ovarian cancer	2.16e-05	0.00079	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PPP1CC—ovarian cancer	2.16e-05	0.00079	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	2.12e-05	0.000773	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—MAPK1—ovarian cancer	2.07e-05	0.000758	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	2.04e-05	0.000745	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	2.02e-05	0.000736	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	2.01e-05	0.000736	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—YAP1—ovarian cancer	2.01e-05	0.000733	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—YAP1—ovarian cancer	2e-05	0.000732	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.98e-05	0.000722	CbGpPWpGaD
Chlorphenamine—HRH1—G alpha (q) signalling events—PIK3CA—ovarian cancer	1.95e-05	0.000714	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	1.9e-05	0.000695	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—MAPK1—ovarian cancer	1.89e-05	0.000689	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—YAP1—ovarian cancer	1.87e-05	0.000682	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.84e-05	0.000673	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—NME2—ovarian cancer	1.79e-05	0.000652	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—MAPK1—ovarian cancer	1.76e-05	0.000643	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CYTB—ovarian cancer	1.76e-05	0.000643	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	1.75e-05	0.000639	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—HRAS—ovarian cancer	1.67e-05	0.000608	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HDAC6—ovarian cancer	1.64e-05	0.000599	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—FASN—ovarian cancer	1.64e-05	0.000597	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—FASN—ovarian cancer	1.63e-05	0.000597	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PPP2R1A—ovarian cancer	1.62e-05	0.000591	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	1.62e-05	0.000591	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.61e-05	0.000588	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SLC5A5—ovarian cancer	1.61e-05	0.000587	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CXCL8—ovarian cancer	1.55e-05	0.000568	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.55e-05	0.000568	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SLC2A1—ovarian cancer	1.55e-05	0.000567	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	1.55e-05	0.000565	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.54e-05	0.000562	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.54e-05	0.000562	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—FASN—ovarian cancer	1.52e-05	0.000556	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.52e-05	0.000554	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SLC5A5—ovarian cancer	1.5e-05	0.000547	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.49e-05	0.000544	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.49e-05	0.000543	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—YAP1—ovarian cancer	1.45e-05	0.00053	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—YAP1—ovarian cancer	1.45e-05	0.00053	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SLC2A1—ovarian cancer	1.45e-05	0.000528	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—XIAP—ovarian cancer	1.42e-05	0.000519	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—HRAS—ovarian cancer	1.41e-05	0.000516	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYP1B1—ovarian cancer	1.39e-05	0.000506	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SMARCA4—ovarian cancer	1.39e-05	0.000506	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EREG—ovarian cancer	1.35e-05	0.000494	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.32e-05	0.000483	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	1.32e-05	0.000482	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PGR—ovarian cancer	1.27e-05	0.000463	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	1.23e-05	0.000449	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.23e-05	0.000448	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ABCB1—ovarian cancer	1.23e-05	0.000447	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—TYMS—ovarian cancer	1.21e-05	0.00044	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—TYMS—ovarian cancer	1.2e-05	0.000439	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PIK3CG—ovarian cancer	1.19e-05	0.000436	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—FASN—ovarian cancer	1.18e-05	0.000432	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PARP1—ovarian cancer	1.18e-05	0.00043	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.16e-05	0.000425	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYTB—ovarian cancer	1.15e-05	0.00042	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ABCB1—ovarian cancer	1.14e-05	0.000417	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL6ST—ovarian cancer	1.13e-05	0.000412	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.12e-05	0.00041	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—TYMS—ovarian cancer	1.12e-05	0.00041	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PIK3CG—ovarian cancer	1.08e-05	0.000396	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.08e-05	0.000393	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PIK3CD—ovarian cancer	1.05e-05	0.000383	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—YAP1—ovarian cancer	1.03e-05	0.000377	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.01e-05	0.000367	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.01e-05	0.000367	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CAV1—ovarian cancer	9.71e-06	0.000355	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CAV1—ovarian cancer	9.7e-06	0.000354	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PPP2R1A—ovarian cancer	9.56e-06	0.000349	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	9.55e-06	0.000349	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PIK3CD—ovarian cancer	9.52e-06	0.000348	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PIK3CB—ovarian cancer	9.14e-06	0.000334	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CAV1—ovarian cancer	9.04e-06	0.00033	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ABCB1—ovarian cancer	8.87e-06	0.000324	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	8.85e-06	0.000323	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	8.83e-06	0.000323	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCL8—ovarian cancer	8.78e-06	0.000321	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TYMS—ovarian cancer	8.71e-06	0.000318	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—FASN—ovarian cancer	8.41e-06	0.000307	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—IL2—ovarian cancer	8.39e-06	0.000307	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PIK3CB—ovarian cancer	8.3e-06	0.000303	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	8.27e-06	0.000302	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PIK3CG—ovarian cancer	8.23e-06	0.000301	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	7.99e-06	0.000292	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCL8—ovarian cancer	7.98e-06	0.000291	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	7.78e-06	0.000284	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	7.76e-06	0.000284	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	7.66e-06	0.00028	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL2—ovarian cancer	7.62e-06	0.000278	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TERT—ovarian cancer	7.59e-06	0.000277	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PIK3CD—ovarian cancer	7.24e-06	0.000264	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CAV1—ovarian cancer	7.03e-06	0.000257	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CAV1—ovarian cancer	7.02e-06	0.000256	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	6.79e-06	0.000248	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	6.78e-06	0.000248	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ESR1—ovarian cancer	6.77e-06	0.000247	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	6.77e-06	0.000247	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—YAP1—ovarian cancer	6.74e-06	0.000246	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL6ST—ovarian cancer	6.66e-06	0.000243	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—APC—ovarian cancer	6.4e-06	0.000234	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PIK3CG—ovarian cancer	6.4e-06	0.000234	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—NRAS—ovarian cancer	6.4e-06	0.000234	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	6.39e-06	0.000234	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PIK3CB—ovarian cancer	6.31e-06	0.00023	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ABCB1—ovarian cancer	6.31e-06	0.00023	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TYMS—ovarian cancer	6.19e-06	0.000226	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—MAPK3—ovarian cancer	6.13e-06	0.000224	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PTEN—ovarian cancer	5.86e-06	0.000214	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PTEN—ovarian cancer	5.85e-06	0.000214	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—MAPK1—ovarian cancer	5.83e-06	0.000213	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—EGFR—ovarian cancer	5.83e-06	0.000213	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PIK3CD—ovarian cancer	5.63e-06	0.000205	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	5.62e-06	0.000205	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—PIK3CA—ovarian cancer	5.57e-06	0.000203	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—KRAS—ovarian cancer	5.51e-06	0.000201	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—FASN—ovarian cancer	5.5e-06	0.000201	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PTEN—ovarian cancer	5.45e-06	0.000199	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.41e-06	0.000197	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.22e-06	0.000191	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PIK3CA—ovarian cancer	5.06e-06	0.000185	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.01e-06	0.000183	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CAV1—ovarian cancer	4.99e-06	0.000182	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ERBB2—ovarian cancer	4.97e-06	0.000181	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PIK3CB—ovarian cancer	4.9e-06	0.000179	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MTOR—ovarian cancer	4.9e-06	0.000179	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.9e-06	0.000179	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCL8—ovarian cancer	4.71e-06	0.000172	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HRAS—ovarian cancer	4.68e-06	0.000171	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CDKN1B—ovarian cancer	4.6e-06	0.000168	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—AKT1—ovarian cancer	4.55e-06	0.000166	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	4.55e-06	0.000166	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CASP3—ovarian cancer	4.51e-06	0.000165	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL2—ovarian cancer	4.5e-06	0.000164	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL6—ovarian cancer	4.48e-06	0.000164	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.44e-06	0.000162	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCND1—ovarian cancer	4.39e-06	0.00016	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CTNNB1—ovarian cancer	4.35e-06	0.000159	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MMP9—ovarian cancer	4.26e-06	0.000156	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PTEN—ovarian cancer	4.24e-06	0.000155	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PTEN—ovarian cancer	4.23e-06	0.000155	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	4.13e-06	0.000151	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	4.13e-06	0.000151	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	4.13e-06	0.000151	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.12e-06	0.000151	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TYMS—ovarian cancer	4.05e-06	0.000148	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4e-06	0.000146	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	3.85e-06	0.00014	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	3.83e-06	0.00014	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—STAT3—ovarian cancer	3.79e-06	0.000138	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—NRAS—ovarian cancer	3.78e-06	0.000138	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	3.62e-06	0.000132	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MYC—ovarian cancer	3.52e-06	0.000129	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	3.48e-06	0.000127	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	3.44e-06	0.000126	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EGFR—ovarian cancer	3.44e-06	0.000126	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—AKT1—ovarian cancer	3.38e-06	0.000123	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—AKT1—ovarian cancer	3.37e-06	0.000123	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CAV1—ovarian cancer	3.26e-06	0.000119	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—KRAS—ovarian cancer	3.25e-06	0.000119	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—AKT1—ovarian cancer	3.14e-06	0.000115	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PTEN—ovarian cancer	3.01e-06	0.00011	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	2.99e-06	0.000109	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.99e-06	0.000109	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.97e-06	0.000109	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TP53—ovarian cancer	2.89e-06	0.000106	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HRAS—ovarian cancer	2.77e-06	0.000101	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL6—ovarian cancer	2.65e-06	9.67e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.61e-06	9.54e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—AKT1—ovarian cancer	2.44e-06	8.92e-05	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—AKT1—ovarian cancer	2.44e-06	8.91e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.28e-06	8.32e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.12e-06	7.76e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.97e-06	7.19e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.73e-06	6.34e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.39e-06	5.07e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.13e-06	4.14e-05	CbGpPWpGaD
